AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 33 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $808,000 | -12.6% | 342,574 | 0.0% | 0.00% | – |
| Q1 2019 | $924,000 | +24.9% | 342,574 | 0.0% | 0.00% | – |
| Q4 2018 | $740,000 | -26.3% | 342,574 | 0.0% | 0.00% | – |
| Q3 2018 | $1,004,000 | +13.8% | 342,574 | +2.9% | 0.00% | – |
| Q2 2018 | $882,000 | -80.2% | 332,892 | +5.4% | 0.00% | – |
| Q1 2018 | $4,447,000 | +27.2% | 315,816 | +6.2% | 0.00% | – |
| Q4 2017 | $3,497,000 | -16.6% | 297,429 | +0.7% | 0.00% | – |
| Q3 2017 | $4,191,000 | +5.5% | 295,362 | +4.6% | 0.00% | – |
| Q2 2017 | $3,974,000 | -10.2% | 282,483 | +6.6% | 0.00% | – |
| Q1 2017 | $4,423,000 | +5.6% | 265,028 | +4.5% | 0.00% | – |
| Q4 2016 | $4,187,000 | +51.5% | 253,601 | +22.6% | 0.00% | – |
| Q3 2016 | $2,764,000 | +278.1% | 206,936 | +87.2% | 0.00% | – |
| Q2 2016 | $731,000 | -23.5% | 110,529 | +2.0% | 0.00% | – |
| Q1 2016 | $955,000 | -18.9% | 108,332 | +14.9% | 0.00% | – |
| Q4 2015 | $1,177,000 | -99.3% | 94,291 | -98.0% | 0.00% | -100.0% |
| Q3 2015 | $180,915,000 | – | 4,675,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
| Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
| Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
| Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
| DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
| UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
| Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
| DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
| Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |